BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28286801)

  • 1. Modulation of Autophagy as a Therapeutic Target for Alzheimer's Disease.
    Steele JW; Fan E; Kelahmetoglu Y; Tian Y; Bustos V
    Postdoc J; 2013 Feb; 1(2):21-34. PubMed ID: 28286801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
    J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagic dysfunction in Alzheimer's disease: Cellular and molecular mechanistic approaches to halt Alzheimer's pathogenesis.
    Uddin MS; Mamun AA; Labu ZK; Hidalgo-Lanussa O; Barreto GE; Ashraf GM
    J Cell Physiol; 2019 Jun; 234(6):8094-8112. PubMed ID: 30362531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulatory Effects of Autophagy on APP Processing as a Potential Treatment Target for Alzheimer's Disease.
    Rahman MA; Rahman MS; Rahman MDH; Rasheduzzaman M; Mamun-Or-Rashid A; Uddin MJ; Rahman MR; Hwang H; Pang MG; Rhim H
    Biomedicines; 2020 Dec; 9(1):. PubMed ID: 33374126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of the autophagy-lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential.
    Zhang W; Xu C; Sun J; Shen HM; Wang J; Yang C
    Acta Pharm Sin B; 2022 Mar; 12(3):1019-1040. PubMed ID: 35530153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired autophagy in amyloid-beta pathology: A traditional review of recent Alzheimer's research.
    Yuan M; Wang Y; Huang Z; Jing F; Qiao P; Zou Q; Li J; Cai Z
    J Biomed Res; 2022 Sep; 37(1):30-46. PubMed ID: 36642915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease-related misfolded proteins and dysfunctional organelles on autophagy menu.
    Correia SC; Resende R; Moreira PI; Pereira CM
    DNA Cell Biol; 2015 Apr; 34(4):261-73. PubMed ID: 25664381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease.
    Liu Z; Li T; Li P; Wei N; Zhao Z; Liang H; Ji X; Chen W; Xue M; Wei J
    Oxid Med Cell Longev; 2015; 2015():352723. PubMed ID: 26171115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy and Alzheimer's Disease.
    Li Q; Liu Y; Sun M
    Cell Mol Neurobiol; 2017 Apr; 37(3):377-388. PubMed ID: 27260250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diminished parkin solubility and co-localization with intraneuronal amyloid-β are associated with autophagic defects in Alzheimer's disease.
    Lonskaya I; Shekoyan AR; Hebron ML; Desforges N; Algarzae NK; Moussa CE
    J Alzheimers Dis; 2013; 33(1):231-47. PubMed ID: 22954671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ROCK1 Is Associated with Alzheimer's Disease-Specific Plaques, as well as Enhances Autophagosome Formation But not Autophagic Aβ Clearance.
    Hu YB; Zou Y; Huang Y; Zhang YF; Lourenco GF; Chen SD; Halliday GM; Wang G; Ren RJ
    Front Cell Neurosci; 2016; 10():253. PubMed ID: 27853422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological modulation of autophagy for Alzheimer's disease therapy: Opportunities and obstacles.
    Deng Z; Dong Y; Zhou X; Lu JH; Yue Z
    Acta Pharm Sin B; 2022 Apr; 12(4):1688-1706. PubMed ID: 35847516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-induced reduction of autophagy-related gene expression is associated with onset of Alzheimer's disease.
    Omata Y; Lim YM; Akao Y; Tsuda L
    Am J Neurodegener Dis; 2014; 3(3):134-42. PubMed ID: 25628964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing Nanochaperone-Mediated Autophagy for Selective Clearance of Pathogenic Tau Protein in Alzheimer's Disease.
    Xu L; Wu X; Zhao S; Hu H; Wang S; Zhang Y; Chen J; Zhang X; Zhao Y; Ma R; Huang F; Shi L
    Adv Mater; 2024 Apr; ():e2313869. PubMed ID: 38688523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
    Reddy PH; Oliver DM
    Cells; 2019 May; 8(5):. PubMed ID: 31121890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoting autophagic clearance: viable therapeutic targets in Alzheimer's disease.
    Friedman LG; Qureshi YH; Yu WH
    Neurotherapeutics; 2015 Jan; 12(1):94-108. PubMed ID: 25421002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent Metabolic Regulation of Autophagy and mTORC1-Early Events in Alzheimer's Disease?
    Shafei MA; Harris M; Conway ME
    Front Aging Neurosci; 2017; 9():173. PubMed ID: 28626421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Implications of Autophagy in Alzheimer's Disease.
    Hamano T; Hayashi K; Shirafuji N; Nakamoto Y
    Curr Alzheimer Res; 2018; 15(14):1283-1296. PubMed ID: 30289076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temsirolimus promotes autophagic clearance of amyloid-β and provides protective effects in cellular and animal models of Alzheimer's disease.
    Jiang T; Yu JT; Zhu XC; Tan MS; Wang HF; Cao L; Zhang QQ; Shi JQ; Gao L; Qin H; Zhang YD; Tan L
    Pharmacol Res; 2014 Mar; 81():54-63. PubMed ID: 24602800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.